The interplay between cancer and the nervous system is reshaping oncology, as researchers uncover how tumors manipulate neural communication to thrive. These findings, alongside broader cancer neuroscience advancements, highlight a paradigm shift in understanding tumor biology.
Cancer’s Neural Exploitation: From Metastasis to Immunotherapy Breakthroughs
The UC case study exemplifies this complexity. A patient with a biologically aggressive pituitary tumor initially achieved remission via surgery and radiation, but the cancer returned. After failing conventional therapies, the team at UC’s Brain Tumor Center used tumor genomics to identify a specific mutation in mismatch repair, leading to a clinical trial. Following a thorough review of tumor genomics, we were able to get the patient signed up for the right clinical trial,
Forbes said. The immunotherapy regimen resulted in the first in the world to have a complete response,
with the tumor vanishing and not returning after treatment cessation.
Stanford’s Discovery: Electrical Synapses Drive Lung Cancer Metastasis
Stanford Medicine’s research, published in a leading journal, reveals a startling mechanism: lung cancer cells in the brain form functional electrical synapses with neurons, accelerating tumor growth. We saw a profound effect on the tumor burden in the animals,
Venkatesh said. Using optogenetics, researchers found that stimulating neurons caused lung cancer tumors to grow larger and invade more aggressively. Further investigation showed part of this growth is mediated by growth factors secreted by the neurons in response to stimulation, but a large part of it is mediated by these functional synapses between cancer cells and neurons,
the team explained.
The study also demonstrated that blocking neuronal electrical signaling slowed cancer growth. An anti-seizure drug that interferes with signaling across synapses significantly reduced cancer cell growth and tumor burden in mice with small cell lung cancers as compared with control animals,
the researchers noted. These findings suggest that targeting neural-cancer communication could open new therapeutic avenues. The electrical communication that drives this membrane depolarization is triggering some form of voltage sensitive signaling and promoting growth in a way that as oncologists, we haven’t been thinking about enough,
Monje said.
Neural-Cancer Dialogue: A Broader Scientific Landscape
Tumors do more than coexist with nerves; they can recruit, rewire, and exploit neural signaling in ways that reshape growth, immunity, and metastatic spread,
the article states. This includes cancer cells releasing neurotrophic factors like BDNF and NGF to foster nerve growth, creating a feedback loop that strengthens tumor-neuron communication.
Chronic stress further exacerbates this dynamic, with catecholamines like epinephrine activating β-adrenergic receptors on cancer cells to promote growth and metastasis. Blocking adrenergic signaling has been shown to inhibit tumor growth and progression in multiple preclinical cancer models,
the study notes. This interplay between the nervous system and cancer is increasingly recognized as a hallmark of malignancy, with different nerve populations exerting opposing effects—sympathetic signaling often promoting tumors, while parasympathetic or sensory pathways may restrain progression.
Implications for Future Treatments
The convergence of these discoveries points to a new frontier in cancer therapy. By targeting neural-cancer communication, researchers may develop more effective treatments for intractable cancers. The UC case study demonstrates the potential of personalized immunotherapy, while Stanford’s work on electrical synapses suggests that disrupting these connections could slow metastasis. It’s humbling, as a clinician, to think about all of the ways that the cancer is taking advantage of the patient, and how much of this pathophysiology we have yet to understand,
Monje reflected. But now we know an important direction we need to pursue to achieve effective therapies for these currently intractable cancers.
As cancer neuroscience advances, the integration of neurobiology into oncology promises to transform how tumors are treated. From immunotherapy breakthroughs to targeting electrical synapses, the field is redefining what’s possible in the fight against cancer. The next steps involving translating these findings into clinical applications, with researchers emphasizing the need for continued exploration of this complex interplay.
